Compare · HIMS vs PRVA
HIMS vs PRVA
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.96B, about 2.3x PRVA ($3.46B).
- Over the past year, HIMS is down 33.4% and PRVA is up 32.4% - PRVA leads by 65.8 points.
- PRVA has been more active in the news (8 items in the past 4 weeks vs 4 for HIMS).
- Both have 25 recent analyst ratings on file.
- Company
- Hims & Hers Health Inc.
- Privia Health Group Inc.
- Price
- $34.89+1.54%
- $27.64+0.64%
- Market cap
- $7.96B
- $3.46B
- 1M return
- +24.89%
- +20.65%
- 1Y return
- -33.44%
- +32.38%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2021
- News (4w)
- 4
- 8
- Recent ratings
- 25
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest HIMS
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)
- Chief Policy Officer Autor Deborah M. covered exercise/tax liability with 15,396 shares and converted options into 32,919 shares, increasing direct ownership by 56% to 48,961 units (SEC Form 4)
- PAO Becklund Irene converted options into 15,971 shares, covered exercise/tax liability with 5,870 shares and sold $370,518 worth of shares (12,063 units at $30.72) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 6,790 units (SEC Form 4) (for tax liability)
- Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 23,315 shares, increasing direct ownership by 6% to 318,314 units (SEC Form 4) to cover taxes
Latest PRVA
- EVP & Chief Financial Officer Mountcastle David sold $16,542 worth of shares (600 units at $27.57) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 186,128 units (SEC Form 4)
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update
- Director Morris Matthew Shawn exercised 112,759 shares at a strike of $2.00 and sold $3,076,868 worth of shares (112,759 units at $27.29) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 68,188 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $680,185 worth of shares (24,734 units at $27.50) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 186,728 units (SEC Form 4)
- Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
- Director Morris Matthew Shawn exercised 135,498 shares at a strike of $2.00 and sold $3,566,335 worth of shares (135,498 units at $26.32) as part of a pre-agreed trading plan (SEC Form 4)
- Director Morris Matthew Shawn exercised 151,322 shares at a strike of $2.00 and sold $3,832,986 worth of shares (151,322 units at $25.33) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David exercised 17,196 shares at a strike of $2.00 and sold $432,995 worth of shares (17,196 units at $25.18) as part of a pre-agreed trading plan (SEC Form 4)
- Privia Health Enters New Jersey
- Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)